Abstract
Stents occupy an important place in the medical field for their widespread application. They have been used in vascular as well as in non-vascular organs for various reasons. Among vascular stents, development of coronary drug eluting stents (DESs) has completely revolutionised the percutaneous coronary intervention. Similarly, attempts have been made to make use of this modality in non-vascular organs. This paper focuses on the preclinical and clinical experience with drug-eluting non-vascular stents with emphasis on drug delivery systems and regulatory requirements for their development.
| Original language | English |
|---|---|
| Pages (from-to) | 105-117 |
| Number of pages | 13 |
| Journal | Journal of Controlled Release |
| Volume | 172 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2013 |
Keywords
- Clinical trials
- Drug eluting stents
- Non-vascular stents
- Preclinical studies
Fingerprint Dive into the research topics of 'Non-vascular drug eluting stents as localized controlled drug delivery platform: Preclinical and clinical experience'. Together they form a unique fingerprint.
Cite this
Shaikh, M., Kichenadasse, G., Choudhury, N., Butler, R., & Garg, S. (2013). Non-vascular drug eluting stents as localized controlled drug delivery platform: Preclinical and clinical experience. Journal of Controlled Release, 172(1), 105-117. https://doi.org/10.1016/j.jconrel.2013.08.010